Blog

Let’s Talk About Maintenance Programs. Did you know that the ToeFX Therapy Light can successfully prevent re-infections of onychomycosis?   It is well known by clinicians and researchers that onychomycosis patients are commonly susceptible to re-infection. It is a very stubborn condition to successfully treat permanently.  Statistics vary, but studies show the rates of reinfection can be 25-50% or more. Furthermore, it should be recognized that reinfection can occur much later. A year or more can pass before symptoms of the condition return. This can be extremely frustrating for patients.   It is important for clinicians to know that patients…

Read More

Patient results and testimonials have shown that ToeFX ClearToe Light Therapy Treatment is now being embraced by clinicians and patients nationwide.  Finally there is a safe and effective solution for onychomycosis to replace topical and oral medications that is painless, drug-free, and has no side effects. The ClearToe Therapy Light uses photodisinfection to target fungal infection. Read about the results and testimonials here. In this blog we will discuss how to make ToeFX Light Therapy Treatments a positive experience for your patient. This can in turn grow your patient base and increase sales for your business.   Offer Superior Care…

Read More

The aging population of Canada needs foot care clinics that provide dedicated services to help the aging population remain mobile. Having healthy feet is of paramount importance to continuing overall mobility. Onychomycosis is a common fungal infection that causes toenail discoloration, thickening, and separation from the nail bed. The condition occurs in 10% of the general population but is more common among older adults where the infection rate is 20% in those over 60 years of age, and 50% in those over 70 years. Is your clinic offering treatments for toenail fungus that are less effective than they could be?…

Read More

Are you struggling to find successful treatments for your patients living with Onychomycosis, commonly referred to as Toenail Fungus? Onychomycosis is a very common and progressive medical condition that negatively affects the lives of many people. It is by far the most common nail infection, representing around 50% of all nail diseases and affecting 10% to 20% of adults. It is especially prevalent in the elderly population. Fungal nail infections don’t usually have serious consequences for people who are otherwise healthy, but they rarely go away on their own. If left untreated, the fungus may stay on just one part…

Read More

Introduction to the Onychomycosis Severity Index (OSI) Onychomycosis, a common disease of the nail unit caused by dermatophytes, nondermatophyte molds, and yeasts, has a prevalence of approximately 10-20% worldwide. Currently no standardized system exists to clinically grade the severity of onychomycotic nail disease. Such a scale is necessary for clinical trial inclusion criteria, for critical evaluation of treatment choice, and to help predict therapeutic outcome. Having quantitative numbers can also assist when discussing these factors with patients and other clinicians. Inconsistences in onychomycotic grading systems can also lead to confusion about interpretation of efficacy. Recently, in a trial of ciclopirox…

Read More

ToeFX is driven by innovation. The vision of our science team is to create the world’s most effective foot care treatments. As such, we continually conduct research to improve our understanding of one of the world’s most stubborn and prevalent infections – onychomycosis.  In order to treat even the most complex cases of onychomycosis, we need to take a holistic treatment approach – from diagnostics to follow-up.  One area of intense focus for ToeFX is diagnostics. We are excited to announce that starting this autumn, we are launching a new collaboration with Professor Jianping Xu from the McMaster University. The…

Read More